# Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment

> **NCT00306124** · PHASE4 · UNKNOWN · sponsor: **University Hospital Muenster** · enrollment: 120 (estimated)

## Conditions studied

- Alzheimer's Disease
- Mild Cognitive Impairment
- Healthy

## Interventions

- **DRUG:** Levodopa

## Key facts

- **NCT ID:** NCT00306124
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** 2008-03
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2007-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00306124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00306124, "Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00306124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
